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Abstract 
 
 
Aim: To report the possible effects of heroin withdrawal on binocular vision. 
 
Methods: To present a case series of patients in whom esotropia developed on 
cessation of heroin use. 
 
Results: In each case the esotropia was concomitant and prismatic correction restored 
binocular single vision. Intermittent spontaneous control occurred in one patient, the 
deviation resolved in one and one patient was lost to follow-up. 
 
Conclusions: Heroin withdrawal should be considered as a cause of acute concomitant 
esotropia. However, accurate history of other medication is needed to ensure that this 
is not the cause of decompensation. 
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Introduction 
 
Heroin is an opiate, a morphine derivative also known as diamorphine. It is produced 
from raw opium obtained from the opium poppy (Papaver Somniferum). Some ocular 
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problems are associated with heroin use. On the street buyers will often taste the 
heroin, which is bitter, to test quality. Quinine is sometimes used as a cutting agent, 
because of its bitter taste, to disguise dilute heroin and also as its hypotensive effect 
intensifies the ‘rush’. Toxic amblyopia, or toxic maculopathy due to quinine has been 
reported in heroin addicts 1-3. Metastatic endophthalmitis (due to candida albicans) 
may occur where lemon juice has been used to dissolve the heroin and injected; or 
some cutting agents may embolize to the eye. Tolerance to heroin rapidly increases 
with use, so that increasing doses are needed for the same effect. The mechanism of 
desensitisation is not fully understood.  
 
A higher number of strabismic children are born to drug dependent women than in the 
normal population 4, although low birth weight and other drug use during pregnancy 
may be significant. Diplopia has been reported, amongst other symptoms, in wound 
botulism in heroin users 5,6. However, it rarely appears amongst possible symptoms of 
withdrawal. 
 
Untreated heroin withdrawal starts within a few hours and reaches its peak 36-72 
hours after the last dose. Symptoms will have mainly subsided after 5 days. The 
genearally accepted signs and symptoms of withdrawal are shown in table 1. 
Himmelsbach7 in 1941 when describing the signs and symptoms of abrupt withdrawal 
states: ‘Occasionally a patient will complain of double vision. Nearly all patients, if 
they try to read, complain of some impairment of vision’. The incidence of  ‘diplopia / 
blurred vision’ during both previous attempts of withdrawal and current attempts at 
withdrawal have been reported in US soldiers who had served in Viet Nam 8 and are 
shown in table 2. However, no detail is given as to the reasons for diplopia and no 
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distinction made between diplopia and blurred vision. In a series of 100 consecutive 
patients admitted to a drug treatment centre, none complained of a recent change in 
vision 9, but visual acuity measurements were not performed. 
 
Acute concomitant esotropia without disruption of fusion (e.g by occlusion) was first 
described by Burian10. Several reports have appeared in recent literature in children11 – 
16 and in children or adults9,17,18. In some instances this type of strabismus has been 
related to a disease or general condition19-23. 
 
Three cases are presented in which acute concomitant esotropia developed in the early 
period of detoxification (planned withdrawal from heroin). 
 
 
Case Series 
 
Case 1. 
 
A 27 year male presented to the accident and emergency department in February 1995 
complaining of diplopia and headache for 8 to 9 days. The patient reported no 
problems with general health and no medication being taken, but commented that his 
left lid used to droop as a child. On examination by an orthoptist visual acuity was 6/5 
either eye and a moderate left to alternating esotropia (Near 30∆ ET; Distance 25∆ 
ET) was present with diplopia. Ocular movements appeared full and fusion was 
demonstrated on the synoptophore. The patient was fitted with a 25∆ base out Fresnel 
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prism left eye on planos and told that he would be referred to an ophthalmologist and 
follow-up would be in clinic. 
 
When the patient attended 6 months later for the clinic appointment, he volunteered 
that diplopia had occurred during rehabilitation for heroin abuse, and that the diplopia 
initially had been intermittent, but had quickly become constant. No medication was 
recorded as being taken at this visit. On examination, esotropia was still present 
without the prism, but the patient was able to control the deviation fixing a light. 
Intermittent left suppression was present when manifest, and the deviation had 
reduced very slightly (Near 18∆ ET; Distance 20∆ ET; Distance R gaze 16∆ ET; 
Distance L gaze 18∆ ET). The Fresnel prism was reduced to 15∆ base out. 
 
One month later the prism was reduced further to 10∆ and over the following 21 
months the patient wore the prism (achieving 55 secs of arc on Frisby), and was able 
to achieve some control without the prism. By June 1997 the prism was no longer 
being worn but intermittent diplopia was troublesome when tired. The angle of 
deviation was 20∆ ET near and distance. A slight ‘A’ pattern was present, 120 secs of 
arc was obtained on the TNO test and whilst good convergence was shown with 
prisms on fusion range testing, only 1∆ of divergence was present for near and 
distance. The patient was listed for surgery at the next visit, but has failed to attend 
since. 
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Case 2 
 
A 31 year old male presented to eye casualty in December 1995 complaining of 
sudden onset of intermittent horizontal diplopia 10 days previously. The diplopia had 
now become constant. He had stopped using heroin 18 days prior to the hospital visit. 
There was no history of eye problems. Visual acuities were 6/5 either eye. On 
examination by the orthoptist a moderate left to alternating esotropia was present for 
near and distance (Near 12∆ ET; Distance 20∆ ET 2∆ RHoT; Distance R gaze 20∆ 
ET; Distance L gaze 20∆ ET). Ocular movements revealed a minimal underaction of 
the right eye on laevoelevation and a minimal underation of the left eye in abduction – 
although there was no increase in the deviation when measured in this position and 
the Hess did not show any underaction of the left eye on laevoversion. Binocular 
single vision was present with Bagolini glasses when the angle was corrected. 
 
The patient was fitted with a 20∆ base out Fresnel prism on planos and failed to attend 
follow-up. 
 
Case 3 
 
A 22 year old female presented to eye casualty in August 1999 complaining of the 
sudden onset of horizontal diplopia 3 days after stopping heroin. Three days prior to 
the withdrawal of heroin, naltrexone hydrochloride (Nalorex), chlordiazepoxide 
(Librium) and clonidine hydrochloride (Catapres; Dixarit) had been started. Ten days 
after onset, she was seen by an orthoptist. Visual acuities were 6/4 right and left. A 
moderate alternating esotropia was present for near and distance (Near and distance: 
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30∆ ET). Fresnel prisms of 10∆ either eye were given on planos. One week later the 
prism was reduced by 6∆ and one week later the patient was able to gain binocular 
single vision unaided and demonstrated a slight esophoria with good recovery (10∆ E) 
and 340 secs of arc on Frisby. The angle of deviation at distance was 35∆ on 
dextroversion and 15∆ on laevoversion, but no limitations of movement were 
recorded. One month later a very slight esophoria was present (Near 6∆ E; Distance 
4∆ E, Distance R gaze 8∆ E; Distance L gaze 4∆ E). 110 seconds of arc was achieved 
on Frisby and a good fusion range present (Near: 40∆ BO to 8∆ BI; Distance 20∆ BO 
to 3∆ BI). The patient failed to attend further follow-up. 
 
 
Discussion 
 
All of these cases presented with acute concomitant esotropia. In each case 
withdrawal from heroin had been without a substitute opiate such as methadone 
hydrochloride; dihydrocodeine phosphate; or buprenorphine. However, details 
regarding other medication in cases 1 and 2 are not known. In case 3 naltrexone 
hydrochloride (Nalorex; an opioid antagonist) was used at the start of the 
detoxification programme. This is usually started following the main withdrawal 
period otherwise patients go into acute withdrawal, however, it is sometimes used to 
precipitate withdrawal in combination with sedation. Also prescribed for this patient 
was Clonidine hydrochloride (Catapres; Dixarit; used to help reduce anxiety, muscle 
cramps, and is hypotensive). This reduces sympathetic tone but blurred vision is not 
listed as a side effect in Martindale24, although it has been reported in one patient with 
no reason given25, and diplopia has been queried as a possible side effect26.  
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 Hargrave27 reports the onset of a concomitant esotropia (angle not stated) in a patient 
(his wife!) who had previously undergone treatment for an exophoria of the 
convergence weakness type. The esotropia was initially attributed to pregnancy, and it 
resolved on taking diazepam (Valium). Diazepam had been stopped previously when 
the likelihood of pregnancy occurred and thus it was concluded that the cessation of 
this drug rather than the pregnancy was the cause of the strabismus. Diazepam is a 
tranquiliser (benzodiazepine based), not an opiate and thus acts differently. It is 
sometimes used to alleviate symptoms of withdrawal in opiate users who are either 
unable to obtain supply of heroin or during self withdrawal (i.e without medical 
help)28. There is no recorded evidence that diazepam was used in any of the cases 
reported in this series, although it is a possibility. It is possible that the strabismus in 
these patients was a side effect of medication used during detoxification. 
 
 
One sign of opiate use is miosis. and whilst pupils are still found to be miosed in long 
term addicts, there is evidence that some level of tolerance develops29. Thus, during 
withdrawal, anisocoria may be observed9 and mydriasis30. 
 
The mechanism for the miosis is unclear. Opiate receptors are located in various areas 
within the brain which include the pretectal area (medial and lateral optic nuclei), 
superior colliculus and ventral nucleus of the lateral geniculate body. However, 
whether it is stimulation in these areas; the lack of inhibition from the cortex to these 
areas or the Edinger-Westphal nucleus; direct action on the neurons subserving the 
parasympathetic light reflex in the Edinger-Westphal nucleus; or stimulation of opioid 
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receptors in the iris sphincter is not known (for review see Murray et al31). Effects on 
accommodation are not generally reported, although one reference to decreased 
accommodation both on use of heroin and withdrawal can be found32. Blur may occur 
as a result of the mydriasis alone. 
 
Various hypotheses may be proposed for the development of the strabismus in these 
cases. Burian and Miller33 state that in some cases with acute concomitant esotropia a 
‘physical or psychic shock may precede the onset’. The start of a detoxification 
programme certainly could be considered as this, particularly where acute withdrawal 
is precipitated (case 3). Hoyt and Good34 consider that a rise in intracranial pressure 
could be relevant to the onset of esotropia in patients with brain tumours, and as 
hypertension is a sign of withdrawal this may be the mechanism here. Concomitant 
esotropia in the presence of raised intracranial pressure with resolution following 
therapy to lower the intracranial pressure has been reported previously35. 
Alternatively, the raised intracranial pressure may have an effect on the 6th nerve(s). 
There are elements in this series of patients which suggest subtle involvement of the 
sixth nerve, namely the A pattern recorded on one visit in case 1 and the increase in 
deviation on horizontal versions in case 3. If the sixth nerve was subtly involved, then 
a vasomotor disturbance could be responsible. The mode of detoxification is not 
known in cases 1 and 2, but in case 3 where acute withdrawal appears to have been 
precipitated the risk of complications would be higher. 
 
Near response related neurons have been identified in the mid brain, in the pretectrum 
and possibly the anterior superior colliculus 36,37. Other pre-motor vergence neurons 
have been identified in the brainstem (for review see Judge38). The equilibrium 
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between convergence and divergence may be altered as tolerance increases leading to 
an imbalance on withdrawal. 
 
Where acute concomitant esotropia develops, detoxification should be suspected as a 
cause and specific questions posed relating to misuse of drugs and current medication. 
Until further study is undertaken, the precise mechanism of the cause remains 
unknown. 
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 Sweating 
Lachrymation and runny nose / sneezing 
Sore eyes 
Mydriasis 
Sore throat 
Yawning 
Feeling hot and cold 
Anorexia and abdominal cramps 
Nausea, vomiting and diarrhoea 
Tremor 
Insomnia and restlessness 
Severe cramps and stiff joints 
Tachycardia, hypertension 
Gooseflesh 
Irritability 
Increased bowel sounds 
Vasomotor disturbances 
Increase in heart rate 
Increase in respiratory rate 
Increase in blood pressure 
Increase in temperature 
 
Table 1: Signs and symptoms of heroin withdrawal 
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Mode of use Reported during previous 
withdrawal attempt 
Observed during 
withdrawal in treatment 
centre 
Smoking 
 
32/178 
18%  
 
38/200 
19% 
Sniffing 
 
15/50 
30% 
 
6/60 
10% 
Injection 
 
17/51 
33.3% 
11/60 
18.3% 
 
 
 
Table 2: Mode of previous use of heroin in US soldiers who had served in Viet 
Nam and incidence of diplopia / blurred vision during withdrawal from Ream et 
al 8 (Number of subjects/total in group and % shown). 
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